This interesting (and sad) letter in the New England Journal of Medicine highlights the shortage of chemotherapy treatments for children suffering from leukemia:
"There was a significant inverse relationship between the amount of prescribed chemotherapy that was administered and the risk of relapse."
The study reinforced the notion that the most important factor in improving survival, even in children with leukemia, is adequate treatment.
Friday, July 25, 2008
Forgotten side of the Iraq war: shortage of meds for cancer patients
Labels:
ALL,
cancer,
competitive intelligence,
Hematology,
leukemia,
market research,
market trends,
oncology,
products
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment